It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Assessing the mutagenicity of chemicals is an essential task in the drug development process. Usually, databases and other structured sources for AMES mutagenicity exist, which have been carefully and laboriously curated from scientific publications. As knowledge accumulates over time, updating these databases is always an overhead and impractical. In this paper, we first propose the problem of predicting the mutagenicity of chemicals from textual information in scientific publications. More simply, given a chemical and evidence in the natural language form from publications where the mutagenicity of the chemical is described, the goal of the model/algorithm is to predict if it is potentially mutagenic or not. For this, we first construct a golden standard data set and then propose MutaPredBERT, a prediction model fine-tuned on BioLinkBERT based on a question-answering formulation of the problem. We leverage transfer learning and use the help of large transformer-based models to achieve a Macro F1 score of >0.88 even with relatively small data for fine-tuning. Our work establishes the utility of large language models for the construction of structured sources of knowledge bases directly from scientific publications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 The Systems Biology Institute, Tokyo, Japan (GRID:grid.452864.9)
2 The Systems Biology Institute, Tokyo, Japan (GRID:grid.452864.9); SBX Corporation, Tokyo, Japan (GRID:grid.452864.9)
3 Global Drug Safety, Eisai Co., Ltd., Tokyo, Japan (GRID:grid.418765.9) (ISNI:0000 0004 1756 5390)
4 Planning Operation, hhc Data Creation Center, Eisai Co., Ltd., Tokyo, Japan (GRID:grid.418765.9) (ISNI:0000 0004 1756 5390)
5 5D Integration Unit, hhc Data Creation Center, Eisai Co., Ltd., Tokyo, Japan (GRID:grid.418765.9) (ISNI:0000 0004 1756 5390)